Merck & Cie Tells ITC Rivals Infringed Supplement Patents

Law360, New York (September 12, 2012, 5:28 PM EDT) -- A Swiss unit of Merck KGaA and others on Monday alleged in the U.S. International Trade Commission that Gnosis SpA and Macoven Pharmaceuticals Inc. are importing and selling products that infringe patents covering Merck's Metafolin, an ingredient in certain reduced folate dietary supplements.

Merck & Cie, Pamlab LLC and the South Alabama Medical Science Foundation lodged an ITC complaint, alleging that Italy's Gnosis and Texas-based Macoven violate Section 337 of the Tariff Act of 1930 by importing products that infringe four patents covering reduced folate dietary...
To view the full article, register now.